Janus kinases: dermatological perspective, a review
Journal of the Egyptian Women’s Dermatologic Society, 2020 Janus kinases (JAKs) are a group of nonreceptor intracellular tyrosine kinases that could modify cytokine-mediated signals through the JAK-signal transducer and activator of transcription pathway.
Hanan R Nada +3 more
doaj +2 more sources
Basics of Janus kinases: a review
Journal of the Egyptian Women’s Dermatologic Society, 2020 Janus kinases (JAKs) are a group of nonreceptor intracellular tyrosine kinases that could modify cytokine-mediated signals through the JAK-signal transducer and activator of transcription (STAT) pathway. The intracellular signaling pathway JAK/STAT has a
Hanan R Nada +3 more
doaj +2 more sources
The Janus kinases (Jaks) [PDF]
Genome Biology, 2004 The Janus kinase (Jak) family is one of ten recognized families of non-receptor tyrosine kinases. Mammals have four members of this family, Jak1, Jak2, Jak3 and Tyrosine kinase 2 (Tyk2). Birds, fish and insects also have Jaks.
John J O'Shea +11 more
core +5 more sources
RUSSIAN AND INTERNATIONAL EXPERIENCE IN THE APPLICATION OF THE JANUS-KINASES INHIBITOR IN RHEUMATOID ARTHRITIS [PDF]
Медицинский совет, 2017 The survey provides data on the use of the only currently available representative of the so-called «small molecules» of the Janus-kinases Inhibitor Tofacitinibe (TOFA) in rheumatoid arthritis (RA) in clinical research and real practice. The positioning
D. E. Karateev +2 more
doaj +2 more sources
Pseudorabies Virus Inhibits Type I and Type III Interferon-Induced Signaling via Proteasomal Degradation of Janus Kinases. [PDF]
J Virol, 2021 Both type I and III interferons (IFNs) play a crucial role in host antiviral response by activating the JAK/STAT (Janus kinase/signal transducer and activator of transcription) signaling pathway to trigger the expression of antiviral IFN-stimulated genes
Yin Y, Romero N, Favoreel HW.
europepmc +2 more sources
Janus kinase inhibitors - their current applications and future prospects [PDF]
Farmacja Polska, 2022 Janus kinase inhibitors are a group of drugs that provide an alternative to conventional therapy for numerous diseases. The most studied drug of this group is tofacitinib.
Natalia Wierzbowska +4 more
doaj +1 more source
Marine Bioactive Molecules as Inhibitors of the Janus Kinases: A Comparative Molecular Docking and Molecular Dynamics Simulation Approach [PDF]
Current Issues in Molecular BiologyEmad A. Ahmed, Salaheldin E. Abdel Salam
exaly +2 more sources
Partial repigmentation of vitiligo with tofacitinib, without exposure to ultraviolet radiation, [PDF]
Anais Brasileiros de Dermatologia, 2020 Vitiligo is a disease that causes macules and achromic and/or hypochromic patches, which can affect from small areas to the entire tegument. Treatment options are few and are generally ineffective.
Melpone Komnitski +3 more
doaj +1 more source
Insights into the Binding Recognition and Susceptibility of Tofacitinib toward Janus Kinases [PDF]
ACS Omega, 2020 Kamonpan Sanachai +5 more
doaj +2 more sources
Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders
Pharmacological Research, 2022 The Janus kinase (JAK) family of nonreceptor protein-tyrosine kinases consists of JAK1, JAK2, JAK3, and TYK2 (Tyrosine Kinase 2). Each of these proteins contains a JAK homology pseudokinase (JH2) domain that interacts with and regulates the activity of ...
Robert Roskoski, Jr.
doaj +1 more source